Articles of poly(butylene succinate) and copolymers thereof

US11844879B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11844879-B2
Application numberUS-202117245573-A
CountryUS
Kind codeB2
Filing dateApr 30, 2021
Priority dateMar 1, 2018
Publication dateDec 19, 2023
Grant dateDec 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

First claim

Opening claim text (preview).

We claim: 1. A method of forming an implant comprising the steps of: (a) preparing a polymeric composition comprising a polymer or copolymer of 1,4-butanediol unit and a succinic acid unit, and a metal catalyst, wherein the metal catalyst comprises scandium, yttrium, titanium, zirconium, vanadium, molybdenum, tungsten, zinc, iron, tin or germanium, and (b) melt processing the polymeric composition to form the implant, wherein the weight average molecular weight of the polymer or copolymer of 1,4-butanediol unit and the succinic acid unit increases by 1% to 100% during the melt processing of the polymeric composition. 2. The method of claim 1 , wherein the catalyst is present at a level of 0.1 to 1,000 ppm. 3. The method of claim 1 , wherein the implant is formed by a process comprising one of the following melt processing processes: melt extrusion, injection molding, melt foaming, film extrusion, melt blowing, melt spinning, compression molding, lamination, thermoforming, molding, spun-bonding, non-woven fabrication, tube extrusion, fiber extrusion, 3D printing by melt extrusion deposition, fused pellet deposition, fused filament fabrication, and selective laser melting. 4. The method of claim 1 , wherein the polymeric composition is heated to a peak temperature between 150° C. and 250° C. during melt processing. 5. The method of claim 1 , wherein the implant comprises a suture; mesh—including mesh for hernia repair, breast reconstruction, and breast lift; breast implant; tissue scaffold; monofilament fiber; multifilament fiber; non-woven; film; injection molded implant; 3D printed implant; tube; foam screw; pin; clip; clamp; nail; bone plate; bone substitute; tack; suture fastener; rivet; staple; suture anchor; bone anchor; meniscus anchors; meniscal implant; intramedullary rod and nail; joint spacer; interosseous wedge implant; osteochondral repair device; spinal fusion device; spinal fusion cage; bone plug; cranioplasty plug; and plug to fill or cover trephination burr holes. 6. The method of claim 1 , wherein the polymeric composition is melt processed to form a fiber, and wherein the fiber has one or more of the following properties: (i) tensile strength of 400 MPa to 2,000 MPa, (ii) Young's Modulus of 600 MPa to 5 GPa, and (iii) elongation to break of 10% to 150%. 7. The method of claim 6 , wherein the fiber is knitted, woven, braided, or formed into a mesh. 8. The method of claim 1 , wherein the polymeric composition is heated to a temperature between 100° C. and 250° C. during melt processing. 9. The method of claim 1 , wherein the catalyst is present in the polymeric composition at a level of 0.1-1000 ppm. 10. The method of claim 1 , wherein the metal catalyst comprises a titanium alkoxide. 11. The method of claim 1 , wherein the weight average molecular weight increases during melt processing by 2% to 60%. 12. The method of claim 1 , wherein the weight average molecular weight increases during melt processing by 2% to 31%.

Assignees

Inventors

Classifications

  • A61L31/06Primary

    obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

  • Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors (A61B17/0642 takes precedence; fixation devices for tendons or ligaments A61F2/0811) · CPC title

  • Intramedullary devices, e.g. pins or nails · CPC title

  • Cortical plates {, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates} · CPC title

  • Wedge osteotomy devices · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11844879B2 cover?
Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include on…
Who is the assignee on this patent?
Tepha Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).